Discontinued — last reported Q4 '24

Operating

Net gains (losses) on investments

ResMed Net gains (losses) on investments decreased by 3410.5% to -$10.13M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 79.4%, from -$5.65M to -$10.13M. Over 2 years (FY 2022 to FY 2025), Net gains (losses) on investments shows an upward trend with a -8.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryCapital Allocation
SignalHigher is better
VolatilityVolatile
First reportedQ1 2018
Last reportedQ4 2024

How to read this metric

Positive values indicate successful investment management, while negative values reflect market volatility or poor asset performance.

Detailed definition

This captures the non-cash gains or losses realized from the sale or revaluation of equity investments and securities. I...

Peer comparison

Common for large corporations with diversified portfolios or strategic minority stakes.

Metric ID: gain_loss_on_investments

Historical Data

18 periods
 Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$5.61M-$4.40M-$1.74M-$11.68M-$3.28M$8.37M$6.42M-$602.00K-$1.89M$13.92M-$15.47M-$680.00K-$1.44M-$5.65M-$2.53M-$6.19M$306.00K-$10.13M
QoQ Change-178.5%+60.6%-572.9%+71.9%+355.1%-23.3%-109.4%-213.8%+836.9%-211.2%+95.6%-111.6%-292.4%+55.1%-144.3%+104.9%<-999%
YoY Change-158.4%+290.0%+469.9%+81.6%-122.6%+116.9%-13.0%+23.8%-140.6%+83.6%-810.3%+121.3%-79.4%
Range-$15.47M$13.92M
CAGR+14.9%
Avg YoY Growth-10.5%
Median YoY Growth+23.8%

Net gains (losses) on investments at Other Companies

Frequently Asked Questions

What is ResMed's net gains (losses) on investments?
ResMed (RMD) reported net gains (losses) on investments of -$10.13M in Q1 2026.
How has ResMed's net gains (losses) on investments changed year-over-year?
ResMed's net gains (losses) on investments decreased by 79.4% year-over-year, from -$5.65M to -$10.13M.
What is the long-term trend for ResMed's net gains (losses) on investments?
Over 2 years (2022 to 2025), ResMed's net gains (losses) on investments has grown at a -8.1% compound annual growth rate (CAGR), from -$12.20M to -$10.30M.
What does net gains (losses) on investments mean?
The profit or loss made from selling or holding financial investments.